WO2008084574A1 - 血管新生阻害剤 - Google Patents
血管新生阻害剤 Download PDFInfo
- Publication number
- WO2008084574A1 WO2008084574A1 PCT/JP2007/067173 JP2007067173W WO2008084574A1 WO 2008084574 A1 WO2008084574 A1 WO 2008084574A1 JP 2007067173 W JP2007067173 W JP 2007067173W WO 2008084574 A1 WO2008084574 A1 WO 2008084574A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- disclosed
- angiogenic activity
- angiogenic agent
- angiogenic
- Prior art date
Links
- 239000004037 angiogenesis inhibitor Substances 0.000 title abstract 2
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 2
- 229920002498 Beta-glucan Polymers 0.000 abstract 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 abstract 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
Abstract
長期間摂取し続けても安全で、かつ経口投与でも血管新生に伴う疾病を予防または治療する効果を充分に発揮する血管新生阻害活性を有する組成物並びにそれを含有する血管新生阻害剤及び血管新生阻害効果を有する飲食品を提供する。
ハナビラタケの子実体及び/又は菌糸体に由来するβ-グルカン又はβ-グルカン含有物を含むことを特徴とする血管新生阻害活性を有する組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008553003A JPWO2008084574A1 (ja) | 2006-12-25 | 2007-09-04 | 血管新生阻害剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006347695 | 2006-12-25 | ||
JP2006-347695 | 2006-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008084574A1 true WO2008084574A1 (ja) | 2008-07-17 |
Family
ID=39608472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/067173 WO2008084574A1 (ja) | 2006-12-25 | 2007-09-04 | 血管新生阻害剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2008084574A1 (ja) |
WO (1) | WO2008084574A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010059106A (ja) * | 2008-09-04 | 2010-03-18 | Unitika Ltd | 糖尿病進行抑制作用を有する組成物 |
JP2010100576A (ja) * | 2008-10-24 | 2010-05-06 | Unitika Ltd | 便秘改善剤 |
JP2014001188A (ja) * | 2012-06-20 | 2014-01-09 | Hiroko Ito | 血管新生阻害剤及び血管新生阻害用飲食組成物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000217543A (ja) * | 1999-01-29 | 2000-08-08 | Nakajima Mitsuhiro | ハナビラタケ抽出物 |
JP2004043441A (ja) * | 2002-05-15 | 2004-02-12 | Bhn Kk | 血管新生阻害剤およびその利用 |
JP2004307453A (ja) * | 2003-04-07 | 2004-11-04 | Bhn Kk | 血管新生阻害剤及びその利用 |
-
2007
- 2007-09-04 WO PCT/JP2007/067173 patent/WO2008084574A1/ja active Application Filing
- 2007-09-04 JP JP2008553003A patent/JPWO2008084574A1/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000217543A (ja) * | 1999-01-29 | 2000-08-08 | Nakajima Mitsuhiro | ハナビラタケ抽出物 |
JP2004043441A (ja) * | 2002-05-15 | 2004-02-12 | Bhn Kk | 血管新生阻害剤およびその利用 |
JP2004307453A (ja) * | 2003-04-07 | 2004-11-04 | Bhn Kk | 血管新生阻害剤及びその利用 |
Non-Patent Citations (2)
Title |
---|
NAOHITO OHNE ET AL.: "Antitumor 1, 3-beta-Glucan from Cultured Fruit Body of Sparassis crispa", BIOL. PHARM. BULL., vol. 23, no. 7, 2000, pages 866 - 872, XP003022924 * |
YAMAMOTO K. ET AL.: "Sparassis crispa beta-glucan no Kekkan Shinsei Sogai Sayo", THE PHARMACEUTICAL SOCIETY OF JAPAN NENKAI YOSHISHU, vol. 127, no. 4, 5 March 2007 (2007-03-05), pages 60, XP003022925 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010059106A (ja) * | 2008-09-04 | 2010-03-18 | Unitika Ltd | 糖尿病進行抑制作用を有する組成物 |
JP2010100576A (ja) * | 2008-10-24 | 2010-05-06 | Unitika Ltd | 便秘改善剤 |
JP2014001188A (ja) * | 2012-06-20 | 2014-01-09 | Hiroko Ito | 血管新生阻害剤及び血管新生阻害用飲食組成物 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008084574A1 (ja) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USD625190S1 (en) | Protective seal for use in cans or the like for packaging beverages or the like | |
WO2005007142A3 (en) | Liquid compositions comprising formoterol | |
WO2008143182A1 (ja) | 甘草ポリフェノールを含有する組成物 | |
WO2007090393A3 (de) | Pharmazeutische zubereitung auf basis vom mikrotabletten | |
WO2006031878A3 (en) | Imidazoquinoline compounds | |
WO2008155999A1 (ja) | Gaba作動性ニューロン賦活剤 | |
WO2006044421A3 (en) | Cardiac safe, rapid medication delivery | |
WO2007088062A3 (en) | Food product comprising a proline specific protease | |
WO2003068170A3 (en) | Enzyme treatment of foodstuffs for celiac sprue | |
WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
WO2008128115A3 (en) | Low-dose doxepin formulations | |
WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
WO2009106975A3 (en) | Activation of innate and adaptive immune responses by a ginseng extract | |
WO2006103672A3 (en) | Spherically shaped substances | |
WO2008105113A1 (ja) | 口腔内用殺菌剤、及び該殺菌剤を含有する食品添加剤 | |
WO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
WO2008155998A1 (ja) | 抗不安抗うつ剤 | |
WO2009017193A1 (ja) | 服用感の優れたアミノ酸含有顆粒製剤 | |
WO2009038095A1 (ja) | セサミン類とビタミンb1類とを配合した組成物 | |
WO2008042101A3 (en) | Probiotics for use in reducing the incidence and duration of illness | |
WO2011043889A3 (en) | Flavor delivery system for a beverage container | |
WO2008084574A1 (ja) | 血管新生阻害剤 | |
WO2008123128A1 (ja) | アディポネクチン産生促進剤 | |
WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
WO2006138571A3 (en) | Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07806641 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008553003 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07806641 Country of ref document: EP Kind code of ref document: A1 |